Increased intracellular reactive oxygen species in patients with these radicals are leakages from the electron transport end-stage renal failure: Effect of hemodialysis.
cyte function have also been detected in chronic renal from patients with end-stage renal failure and healthy control subjects. The PMA-induced ROS increase was significantly failure [11] [12] [13] .
higher in lymphocytes from patients with end-stage renal failThere is little evidence that increased oxidative stress ure compared with healthy control subjects (P Ͻ 0.01). In in patients with chronic renal failure is associated with patients with end-stage renal failure, not yet on renal replaceuremic complications [14, 15] . In particular, increased ment therapy, the PMA-induced ROS was also significantly higher compared with healthy control subjects. The PMAhydroxyl radicals have been associated with uremic hyperinduced ROS increases were significantly inhibited by catalase, tension [16] . Since lipid peroxidation products, malondibut not by superoxide dismutase or the superoxide dismutase aldehyde and 4-hydroxyalkenals, were found to be inmimetic, tempol. PMA-induced ROS was significantly reduced creased in plasma of patients with end-stage renal failure by tyrphostin A51 in lymphocytes from patients with end-stage renal failure and from healthy control subjects (each P Ͻ 0.01), before and after hemodialysis [17] , both a weakening of indicating the involvement of a tyrosine kinase-dependent antioxidant defenses or an increased production of ROS pathway. In patients with end-stage renal failure, the spontaneduring hemodialysis might be involved in the pathogenesis ous and the PMA-induced production of ROS was not signifiof the uremic syndrome or in the development of complicantly different before and after hemodialysis.
Conclusions. Regular hemodialysis sessions using biocomcations during long-term hemodialysis treatment.
patible membranes have no effect on the elevated intracellular
In contrast to measurements of plasmic lipid peroxida-ROS in patients with end-stage renal failure.
tion products or the activity of antioxidant enzymes in erythrocytes, determinations of intracellular ROS may reflect the cellular oxidative stress more directly. ThereReactive oxygen species (ROS) are byproducts of norfore, in the present study, we investigated the intracellumal metabolic processes in cells. The major sources of lar ROS levels, for example, superoxide radical (O • 2 ) and hydrogen peroxide (H 2 O 2 ), in patients with end-stage re-and stimulated levels of ROS, and intracellular ROS were not significantly changed during hemodialysis treatment. [21] [22] [23] [24] . undergoing maintenance hemodialysis for 22 Ϯ 6 months DCF-DA is a nonpolar compound that readily diffuses (mean Ϯ SEM), were enrolled in this study. The cause into cells, where it is hydrolyzed to the nonfluorescent of end-stage renal failure was chronic glomerulonephritis polar derivative DCFH and thereby trapped within the in 10 cases, diabetic nephropathy in 10 cases, nephrosclecells [22] . In the presence of ROS, DCFH is oxidized to rosis in 7 cases, and polycystic kidney disease in 1 case.
METHODS
the highly fluorescent 2Ј,7Ј-dichlorofluorescein (DCF). All patients were stable and free from intercurrent ill-
The level of DCF fluorescence, reflecting the concentraness. As confirmed by the clinical examination and roution of ROS, was monitored using a fluorescence spectrophotometer (F-2000 Hitachi Ltd., Tokyo, Japan) at 534 tine laboratory examination, patients were in a good nm emission with an excitation wavelength of 488 nm. state of health. All of the patients were routinely dialyzed
To minimize the DCFH, photo-oxidation samples were for four to five hours three times weekly using biokept in the dark, and the fluorescence was rapidly colcompatible membranes (polysulfone; Fresenius Medical lected within 60 seconds using identical parameters, such Care, Bad Homburg, Germany; acrylonitrile and sodium as bandwidth and brightness, for all samples. Under methallyl sulfonate copolymer; Hospal, Nü rnberg, Gerthese circumstances, spontaneous photooxidation of the many) with no dialyzer reuse. The dialysates used were dye was less than 1%. Using H 2 O 2 , a calibration curve bicarbonate based. Kt/V values (the amount of plasma of the DCF fluorescence could be measured. As shown cleared of urea divided by the urea distribution volume)
in Figure 1 , the DCF fluorescence showed a nonlinear was measured according to the formula: increase with increasing H 2 O 2 concentrations. Kt/V ϭ Ϫln (R Ϫ 0.03) ϩ (4 Ϫ 3.5 ϫ R) ϫ UF/W Lymphocytes were incubated for 30 minutes with phorbol-12-myristate-13-acetate (PMA; Sigma Chemical where R is the post-/pre-plasma urea nitrogen ratio; UF Co., Deisenhofen, Germany). The inactive phorbol ester is the ultrafiltrate volume (L) removed, and W is the 4␣-phorbol-12,13-didecanoate (4␣-PDD) was used as a postdialysis weight (kg) hibitor), 2-Amino-4-(3Ј,4Ј,5Ј-trihydroxyphenyl)-1,1,3-tricyanobuta-1,3-diene (tyrphostin A51; 4 mol/L; tyrosine Preparation of lymphocytes kinase inhibitor), SOD (40 g/mL, superoxide radical Blood samples were drawn from the antecubital veins scavenger), tempol (membrane-permeable SOD-mimetic; of healthy control subjects and from the arterial side of Alexis Biochemicals, Grü nberg, Germany), and catalase the arteriovenous fistula of patients with end-stage renal (5 g/mL, H 2 O 2 scavenger). All substances were freshly failure. The lymphocytes were isolated from heparinized prepared from stocks for each day's experiments, and blood samples according to previously described proceconcentrations given indicate final concentrations after dure [20] . In brief, the blood was centrifuged at 150 ϫ g all additions. All substances were purchased from Sigma for 15 minutes, and the supernatant was removed. The or Calbiochem (La Jolla, CA, USA), if not indicated blood cells were then diluted with physiological salt soluotherwise. tion (1:1), and 5 mL of the mixture were layered on 3 Statistics mL of lymphoprep (5.6% wt/vol; density 1.077 g/mL; Nycomed, Oslo, Norway) and then centrifuged for 15 Data are means Ϯ SEM. Differences were compared minutes at 240 ϫ g. The lymphocyte interphase was with the Wilcoxon-Mann-Whitney test or t-test using the computer software GraphPad Prism 2.0 (GraphPad carefully aspirated and washed in physiological salt solu- Software, San Diego, CA, USA). Two-tailed values of P Ͻ 0.05 were considered significant.
RESULTS
The spontaneous production of ROS in lymphocytes was monitored over a period of 30 minutes. Within 30 minutes, ROS increased by 88 Ϯ 4% (N ϭ 27) above the initial level in unstimulated lymphocytes from healthy control subjects, whereas ROS increased by 128 Ϯ 10% in lymphocytes from patients with end-stage renal failure (N ϭ 28, P Ͻ 0.01 compared with healthy control subjects). Two types of biocompatible membranes (polysulfone, and acrylonitrile and sodium methylsulfonate co- the spontaneous production of ROS was not significantly different compared with healthy control subjects (99 Ϯ 15%, N ϭ 11, vs. 88 Ϯ 4%, N ϭ 27, P ϭ 0.32). P Ͻ 0.01; Fig. 3 ). The PMA-induced ROS in lymphocytes Lymphocytes were stimulated with the phorbol ester was not significantly different between the two dialyzers PMA. A concentration response curve is shown in Figure  ( polysulfone, 250 Ϯ 52%; AN69, 254 Ϯ 43%, P ϭ 0.80). 2. PMA dose-dependently induced the production of
In patients with end-stage renal failure, not yet on renal ROS, and saturation was reached at a concentration of replacement therapy, the PMA-induced ROS was sig-100 nmol/L. Additional experiments showed that the nificantly higher compared with healthy control subjects inactive phorbol ester 4␣-PDD did not induce the pro-(631 Ϯ 149%, N ϭ 11, vs. 99 Ϯ 1%, N ϭ 27, P Ͻ 0.01). duction of ROS in lymphocytes.
The PMA-induced production of ROS was signifiThe PMA (100 nmol/L)-induced production of ROS cantly reduced in the presence of the H 2 O 2 scavenger was significantly higher in lymphocytes from patients catalase (5 g/mL) both in lymphocytes from patients with end-stage renal failure compared with healthy control subjects (252 Ϯ 33%, N ϭ 28, vs. 99 Ϯ 1%, N ϭ 27, with end-stage renal failure (148 Ϯ 10%, P Ͻ 0.01) and
In patients with end-stage renal failure, the PMAinduced production was measured before and after the hemodialysis session using biocompatible membranes. The spontaneous ROS production was not significantly different before and after hemodialysis (128 Ϯ 10% vs. 134 Ϯ 15%). As indicated in Figure 4 , the PMA-induced ROS production was not significantly different before and after hemodialysis (252 Ϯ 33% vs. 297 Ϯ 42%). In addition, the PMA-induced production was significantly reduced both before and after hemodialysis in the presence of the H 2 O 2 scavenger catalase, but not in the presence of the superoxide radical scavenger SOD. The PMA-induced production was significantly reduced both before and after hemodialysis in the presence of the specific protein kinase C inhibitor Ro-32-0432 and in the presence of the specific tyrosine kinase inhibitor tyrphostin A51. hemodialysis treatment. The production of ROS is part of cellular life, and in lymphocytes, ROS production may be necessary for activation and proliferation [25, 26] . On the other hand, increased ROS may be harmful to cells in healthy control subjects (67 Ϯ 8%, P Ͻ 0.01; Fig. 3) .
and cause functional disabilities. In fact, higher ROS On the other hand, in the presence of the superoxide concentrations have been shown to cause cell damage radical scavenger SOD (40 g/mL), the PMA-induced [2, 3] . The generation of ROS leads to the activation of production of ROS was not significantly changed, neither protein tyrosine kinases followed by the stimulation of in lymphocytes from patients with end-stage renal failure several signaling systems, including mitogen-activated (234 Ϯ 29%) nor in healthy control subjects (117 Ϯ protein kinases, nuclear transcription factors, caspases, 16%; Fig. 3) . In additional experiments, the membraneand intracellular calcium concentrations [27, 28] . Impermeable SOD-mimetic tempol was used. In the prespaired lymphocytic function in chronic renal failure has ence of the SOD-mimetic tempol, the PMA-induced been described earlier [11] [12] [13] . The present study indi-ROS production was not significantly reduced in lymcates that one mechanism causing impaired lymphocytic phocytes from patients with end-stage renal failure function in chronic renal failure may be due to an in-(1072 Ϯ 278%, N ϭ 5).
creased ROS production. As expected, the PMA-induced production of ROS Using specific inhibitors, it could be shown that the was significantly reduced in the presence of the specific PMA-induced production of ROS was mediated by a tyroprotein kinase C inhibitor Ro-32-0432 (140 nmol/L), sine kinase-dependent pathway. These pathways could both in lymphocytes from patients with end-stage renal be observed both in patients with end-stage chronic renal failure and healthy control subjects (each P Ͻ 0.01).
failure and in healthy control subjects. These findings However, the PMA-induced production of ROS was also support earlier reports on the regulatory effect of tyrosignificantly reduced in the presence of a specific tyrosine sine kinase on production of ROS in other cells [29] . At kinase inhibitor, tyrphostin A51 (4 mol/L), both in lympresent, it is not known whether the increased spontanephocytes from patients with end-stage renal failure and ous production of ROS in patients with end-stage chronic healthy control subjects (each P Ͻ 0.01; Fig. 3 ). These renal failure may be caused by changes of activity of the data indicate that the PMA-induced ROS production is mediated by a tyrosine kinase-dependent pathway.
tyrosine kinase caused by uremic toxins. 
